Main-blog-page-header

Sharing perspectives leads to greater understanding and fuels innovation. The ​Optum Insights ​blog is where we share our perspective and challenge preconceptions to clear a new path forward



  • New medication approved for acute treatment of migraine ― Ubrelvy™ (ubrogepant) tablets

    by
    • Clinical Connection team
    | Jan 16, 2020
    Tag Icon
    FDA approved, Migraine, clinical info, Clinical
    The U.S. Food and Drug Administration (FDA) has approved a new medication to treat acute (immediate) migraine with or without aura (often described as a visual disturbance such as flashing lights) in adults.


  • NY Workers’ Compensation Board announces drug formulary webinars in mid-January

    by
    • Policy Matters team
    | Jan 09, 2020
    Tag Icon
    NY Workers’ Compensation Board, formulary, New York
    NY Workers’ Compensation Board announces drug formulary webinars in mid-January. The webinars will educate payers, providers and other stakeholders about the latest updates to the drug formulary process.


  • FDA issues safety warning about serious breathing problems with gabapentin and pregabalin (Lyrica®)

    by
    • Clinical Connection team
    | Dec 23, 2019
    Tag Icon
    Clinical, recall, FDA, Lyrica
    On December 19, 2019, the U.S. Food and Drug Administration (FDA) issued a warning that patients with certain respiratory risk factors who are using gabapentin (Neurontin®, Gralise®, Horizant®) or pregabalin (Lyrica®, Lyrica® CR) may experience serious breathing difficulties.


  • The Optum 2020 continuing education schedule

    by
    • OWCA
    | Dec 18, 2019
    Tag Icon
    Continuing Education
    The Optum 2020 continuing education schedule has the information you want so you can earn the CE credits you need


  • 5 Tips to Prepare for the NY State Workers' Comp Formulary

    by
    • Policy Matters team
    | Dec 03, 2019
    Tag Icon
    Workers' Compensation, formulary, New York
    The New York State Workers' Comp Formulary implementation starts December 5, 2019. These 5 tips will help you get ready.


  • California Insurance Guarantee Association is not a primary payer under Medicare

    by
    • Rafael Gonzalez Esq. President Optum Settlement Solutions
    | Nov 22, 2019
    Tag Icon
    Medicare Insights, Medicare Set-Aside, MSA
    On October 10, 2019, the United States Court of Appeals for the Ninth Circuit published its opinion on California Insurance Guarantee Association v. Azar, concluding that CIGA is not a primary plan under the Medicare secondary payer provisions, but an insurer of last resort, therefore, is under no obligation to reimburse CMS for conditional payments made on behalf of workers’ compensation insureds.


  • CMS announces accessibility to Open Debt Reports

    by
    • Rafael Gonzalez
    | Nov 20, 2019
    Tag Icon
    Medicare Set-Aside, MSA, Medicare Secondary Payer, MSPA Claims, CMS
    The Centers for Medicare and Medicaid Services (CMS) recently published Version 4.7 of the Medicare Secondary Payer Recovery Portal (MSPRP) User Guide. A notable update in this version is accessibility to Open Debt Reports for account managers. As stated in the user guide, the Open Debt Report page displays the status of open debts with account receivable balances greater than zero.



Stay informed by receiving latest updates

Do you have a question about a blog post?